Discover Agios Pharmaceuticals' Q4 2024 earnings highlights, growth plans for Pyrukynd in thalassemia & sickle cell, and insights on safety, clinical ...
Agios Pharmaceuticals reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of -$1.44 compared to the forecast of -$1.68. The company also ...
Indie Spotlight column reviews the releases from Randall Bramblett, David J, The Tasty Kings With Blondie Chaplin, Lance Cowan and Rees Shad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback